Clinical Trials Logo

Endometrium Cancer clinical trials

View clinical trials related to Endometrium Cancer.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06312917 Completed - Physical Activity Clinical Trials

Effect of Physical Activity Intervention on Overweight and Obese Patients With Endometrial Cancer

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

This study evaluated the clinical outcome of exercise management on patients with endometrial cancer treated with fertility preservation, including the effect of complete response rate, complete response time, recurrence rate, recurrence time, etc., and physical composition, to evaluate the effectiveness of physical activity on weight management.

NCT ID: NCT06187558 Completed - Endometriosis Clinical Trials

Suspension of the Pelvic and Abdominal Organs During Minimally Invasive Surgery

Start date: March 1, 2019
Phase:
Study type: Observational

The goal of this retrospective observational study is to evaluate the efficacy, safety, and practicality of an organ suspension technique with adjustable tension suture in facilitating minimally invasive gynecologic surgeries at the University Hospital of Cagliari, Italy. The main questions it aims to answer are: - Is the organ suspension technique using adjustable tension suture both cost-effective and practical for minimally invasive gynecologic surgeries? - How safe, effective, and feasible is this suspension technique when applied to patients with benign or malignant gynecological diseases undergoing laparoscopic surgery? Participants in this study underwent laparoscopic surgery involving the organ suspension technique, which includes: - The use of a modified Foley catheter and Polyglactin suture for organ suspension. - The collection of preoperative and postoperative data, such as operation times, blood loss, hospital stay duration, and short-term postoperative complications. This study does not include a comparison group, focusing instead on the direct outcomes and experiences of the participants who underwent the specified surgical technique.

NCT ID: NCT05246462 Completed - Cervix Cancer Clinical Trials

The Effect of Logotherapy on Mental Health in Gynecological Cancer Patients

Start date: March 25, 2019
Phase: N/A
Study type: Interventional

Gynecological cancers negatively affect women's sexuality, fertility, body image, and self-perception, resulting in deterioration in their psychological health. The aim of this study is to examine the effects of logotherapy on traumatic stress symptoms, post-traumatic growth, finding meaning in life, and spiritual well-being in gynecological cancer patients. No research has yet been found that examines logotherapy's symptoms of post-traumatic stress, post-traumatic growth, the meaning of life, and the spiritual well-being of gynecological cancer patients. The study was conducted in a single-blind randomized controlled trial with 68 women with gynecological cancer. The study is registered at ClinicalTrials.gov NCT… While logotherapy interviews including seven sessions were made in the experimental group, only routine nursing care was given to the control group. The data were collected using the Personal Information Form (PIF), the Traumatic Stress Symptom Scale (TSSS), the Post-Traumatic Growth Inventory (PTGI), the Meaning in Life Questionnaire (MLQ), and the Spiritual Well-Being Scale (SWBS). To analyze the data, descriptive statistics and parametric-nonparametric tests were used in the analysis of the data.

NCT ID: NCT04603599 Completed - Endometrium Cancer Clinical Trials

Relationship of Endometrial Cancer and Serum Soluble L1CAM Level

Start date: January 1, 2019
Phase:
Study type: Observational

The aim of this study is to evaluate the effect of serum soluble L1CAM (sL1CAM) on the diagnosis and prognosis of endometrial cancer. This prospective randomized controlled trial will be conducted in patients who have undergone endometrial biopsy and whose pathology results are reported as benign endometrial changes, endometrial hyperplasia, or endometrial cancer. The sL1CAM level between groups will be compared. The relationship between prognostic factors and serum sL1CAM will be evaluated in patients with endometrial cancer.

NCT ID: NCT04205864 Completed - Endometrium Cancer Clinical Trials

Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer.

Start date: December 20, 2019
Phase: N/A
Study type: Interventional

To compare the incidence of lymphocele in Endometrial cancer patients with thrombin gel matrix used and not used during pelvic lymph node dissection.

NCT ID: NCT04175067 Completed - Oxidative Stress Clinical Trials

Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium Cancer

Start date: August 1, 2018
Phase:
Study type: Observational

The purpose of this study is to investigate thiol‑disulfide balance in early stage endometrium cancer patients.

NCT ID: NCT03899441 Completed - Clinical trials for Perioperative/Postoperative Complications

Multimedia Aid Gynecologic Counseling and Consent

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

This is an interventional trial to introduce two short animated videos into preoperative counseling/consent and to compare patient comprehension and satisfaction with a multimedia approach compared to standard of care currently. The investigators anticipate that patients will retain more information about their surgery and peri-operative care and will be more satisfied with a multimedia approach.

NCT ID: NCT03245736 Completed - Prostate Cancer Clinical Trials

Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.

Start date: August 23, 2017
Phase: Phase 2
Study type: Interventional

The purpose of the trial is to evaluate efficacy and safety of continued treatment with tisotumab vedotin.

NCT ID: NCT02997553 Completed - Clinical trials for Head and Neck Cancer

Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery

GASVERT
Start date: November 29, 2017
Phase: Phase 3
Study type: Interventional

This is a single-center prospective clinical trial to evaluate non-inferiority of indocyanine green guided sentinel lymph node biopsy compared with the gold standard Technecium99 guided sentinel lymph node biopsy in patients with cancers and subjected to surgery. The diagnostic performance and the tolerance of indocyanine green (ICG) to the radio-isotope (Techniciun99) in the detection of sentinel lymph nodes will be assess using an "Optonuclear" probe (EURORAD S.A.) and QUEST camera

NCT ID: NCT02552121 Completed - Bladder Cancer Clinical Trials

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Start date: November 30, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the trial is to establish the tolerability of tisotumab vedotin (HuMax-TF-ADC) dosed three times every four weeks (3q4wk) in a mixed population of patients with specified solid tumors.